Phio Pharmaceuticals Corp.
PHIO
$1.09
-$0.03-2.68%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.95M | -7.09M | -6.77M | -7.15M | -7.42M |
| Total Depreciation and Amortization | 2.00K | 0.00 | 1.00K | 35.00K | 78.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 246.00K | 185.00K | 149.00K | 141.00K | 237.00K |
| Change in Net Operating Assets | 434.00K | -239.00K | 239.00K | -138.00K | -1.01M |
| Cash from Operations | -7.27M | -7.14M | -6.38M | -7.11M | -8.11M |
| Capital Expenditure | -13.00K | -6.00K | -3.00K | -1.00K | 0.00 |
| Sale of Property, Plant, and Equipment | 9.00K | 9.00K | 9.00K | 9.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -4.00K | 3.00K | 6.00K | 8.00K | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 12.62M | 13.22M | 13.18M | 4.00M | 5.05M |
| Repurchase of Common Stock | -31.00K | -1.00K | -1.00K | -5.00K | -5.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | 0.00 |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -1.00K | -1.00K | -1.00K | -1.00K |
| Cash from Financing | 12.59M | 13.21M | 13.17M | 4.00M | 5.04M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.32M | 6.08M | 6.80M | -3.11M | -3.07M |